Chennai, October 12th, 2023: REFCOLD India, 2023, South Asia’s leading exhibition and conference dedicated to refrigeration and cold-chain technologies, commenced today at the Chennai Trade Centre, Chennai. Organised in collaboration between the Indian Society of Heating, Refrigerating and Air Conditioning Engineers (ISHRAE) and Informa Markets, REFCOLD India 2023 is set to redefine the industry landscape. This well-reputed event represents a significant step forward in the refrigeration and cold-chain sector, unveiling a vast potential cold-chain market of around INR 4.3 trillion by 2027.
The event’s grand inauguration was spearheaded by a rich array of dignitaries including Guest of Honour – Dr. R Velraj, Vice Chancellor, Anna University; Mr. Raja M Sriraam, Chairman, RECFOLD Chennai, ISHRAE; Mr. Yogesh Thakkar, National President, ISHRAE, Mr. Anoop Ballaney, National President Elect, ISHRAE and Mr Yogesh Mudras, Managing Director, Informa Markets in India.
The 6th gala edition of REFCOLD India brought together top experts, businesses, and thought leaders who are driving the industry’s transformation with over 200 exhibitors, including an impressive lineup of industry giants such as BlueStar, Copeland, Rinac India, Tecumseh, Daikin, K-Flex, Yaskawa, and Danfoss, among others. The show anticipates more than 10,000 visitors, industry leaders, and professionals, for dynamic business opportunities, knowledge-sharing sessions, and networking.
Speaking on the occasion, Mr Yogesh Thakkar, National President ISHRAE said, тАЬThe adoption of integrated cold chain solutions has the potential to significantly revolutionize the traditional perishables sector, bringing about substantial changes in the market landscape and overall growth. This is especially important in a country where agriculture employs 60% of the population. To harness the potential of integrated cold chain solutions, there is a need to optimise logistics, enhance value addition facilities, adopt green refrigeration practices, and adopt energy-efficient cooling systems and natural refrigerants ultimately improving efficiency across the supply chain. Similarly, the Indian organized food industry is a vast arena with significant potential. This underscores the substantial room for growth in the food delivery sector, which, when integrated with advanced refrigeration and cold chain solutions, can further enhance food quality, safety, and delivery efficiency.тАЭ
тАЬThe pandemic acted as a catalyst, propelling India’s online food delivery market to reach approximately $21 billion by 2026, with a remarkable compound annual growth rate (CAGR) of nearly 30%тАЭ, he further added.
With the valuable support of MOFPI (Ministry of Food Processing Industries Government of India), other esteemed associations like IIR (International Institute of Refrigeration), NCCD (National Centre for Cold-chain Development), IDA (Indian Dairy Association), IIAR (International Institute of Ammonia Refrigeration) and more, the event successfully bridged the gap between suppliers and buyers.
REFCOLD India offers an enriching programme of Conferences and exhibitions by technical experts of the industry focusing on Industrial Refrigeration along with Cold Chain and Reefer Transportation, Seminars and workshops on pharma, dairy, fishery and hospitality encouraging continuous learning and skill advancement. The expo covered important topics on Heat pump integrated thermal storage for dairy applications, Natural Refrigerants, Innovative Design or Technology for Net Zero Cold Storage Plants, Challenges on Dairy Processing and Storage, Safety Standards and Trouble Shooting of Refrigeration Plants, to name a few.
Commenting on the significance of REFCOLD India 2023, Mr Yogesh Mudras Managing Director, Informa Markets in India said тАЬREFCOLD India provides a transformative journey that unlocks opportunities for fresh horizons and valuable collaborations. The expo offers a plethora of opportunities to connect with industry experts and learn about cutting-edge technologies. Furthermore, the government is also taking proactive steps to boost the refrigeration and cold chain industry by establishing extensive cold storage facilities nationwide. This initiative aims to minimize food wastage, encouraging eco-friendly refrigeration practices, while simultaneously stimulating economic growth. The added attractions including our content-rich conference that aligns with the theme of тАШPreserve through Innovation for a Better FutureтАЩ will gather experts, stalwarts, and key organizations and provide the momentum the market truly deserves!тАЭ
Distinguished speakers that graced the event included notable figures like Mr. Arvind Surange, Chairman and Managing Director of ACR Project Consultants Pvt Ltd; Dr. Lambert Kuijpers, an Environmental Consultant hailing from Venlo, Netherlands; Mr. C.P. Charles, a Central Executive Committee Member at the Indian Dairy Association; Dr. Alex Pachai, representing Global Consultancy, ApS in Denmark; Dr. Omar Abdulaziz, a Mechanical Engineer affiliated with The American University in Cairo, Egypt; and Mr. Jiju Nair, who holds the position of National Marketing Manager at Honeywell, among others.
Insights on IndiaтАЩs Cold Storage and Refrigeration Technology Market:
Advancements in refrigeration technology have led to energy-efficient systems, particularly beneficial in high-energy industries like chemical manufacturing. These optimized systems and eco-friendly refrigerants not only lower carbon footprints but also reduce emissions and water waste compared to traditional cooling methods like cooling water towers.
Additionally, in India, where agricultural production is vast, but access is limited, the cold chain sector plays a vital role, further driven by the growth of organized food delivery and e-commerce segments.
REFCOLD India gathers experts from the global and Indian refrigeration sectors to drive innovation and combat food waste. It highlights the importance of cold chain management,
Mr. Madhur Sehgal, Head Climate Solutions, Danfoss said, тАЬWe are bringing an exciting opportunity to all of you to have an exclusive visit to our lead Platinum Campus on 13th October 2023. This is a unique opportunity to witness the state-of-the-art campus with next-generation R & D and production facilities, an application development center, and a customer experience center showcasing the live working performance of our products in diverse industry applications. We will also be pleased to showcase the use of the latest technologies and specific actions on our campus on HVAC, Renewable Energy, Water, and waste management, leading to faster progress toward our Net Zero Emission goals. Please join us for this exclusive event on 13th October and discover how Danfoss can help you achieve your goals of clean growth and development.тАЭ
Mr. M Srinivas Reddy, Vice President, Commercial Refrigeration Business Group, Blue Star stated, тАЬWe, at Blue Star, recognise REFCOLD as the perfect platform to showcase various refrigeration solutions. We are confident that it will help us reach our target audience well and we wish REFCOLD a huge success.тАЭ
On the sidelines of the expo, Informa Markets in India launched its 4th edition of the Festivity of Business campaign for this yearтАЩs high season. As the autumn season blankets India with its diverse array of festivals, the initiative will be a vibrant tribute to India’s economic triumphs and its burgeoning global influence. This year, Informa Markets in IndiaтАЩs initiative encompasses a rich tapestry of over 40 events till year-end, including ten signature Expos, along with distinctive Conferences, Industry Awards, Buyer-Seller Meets, and Training programmes in influential sectors. All these are poised to elevate the nation to new heights.
тЧП Child presented with jaundice and was diagnosed with Langerhans Cell Histiocytosis with
severe liver dysfunction, with bilirubin levels rising to 10тАУ12 mg/dL
тЧП Modified low-dose chemotherapy achieved a 90тАУ95% response, while recurrent UTIs led to the diagnosis and surgical correction of congenital vesicoureteric reflux before liver transplantation тЧП Following liver transplantation, the child received four additional rounds of chemotherapy and
is now free of LCH and recurrent urinary infections
Chennai, 30 th September, 2026: In yet another case highlighting the importance of a multidisciplinary approach in managing complex pediatric conditions, doctors at Rainbow ChildrenтАЩs Hospital successfully performed a liver transplant on a 3-year-old child diagnosed with the rare systemic disorder Langerhans Cell Histiocytosis (LCH), whose treatment was further complicated by an underlying congenital abnormality of kidneys causing recurrent urinary tract infections. The child’s treatment involved multiple specialties and required the medical team to address one clinical challenge after another before the child could safely undergo transplantation. The child was initially brought to Rainbow ChildrenтАЩs Hospital with complaints of jaundice. Investigations revealed LCH, a rare systemic disorder, with significant liver dysfunction. Given the severity of the liver involvement, the initial focus was on controlling the underlying LCH and improving the child’s condition before transplantation. Chemotherapy was therefore initiated. However, with the liver already severely compromised, the treatment itself had to be carefully adapted. The child was placed on a low-dose chemotherapy which showed only partial response. Now there is a significant advancement in the newer targeted therapy which resulted in a good response in the LCH. While this represented a significant response to treatment, the child’s clinical journey became more complex when he began developing recurrent urinary tract infections during chemotherapy. Rather than treating the infections as an isolated complication, the medical team investigated the underlying cause. Evaluation by the pediatric nephrology and urology teams revealed congenital vesicoureteric reflux, a condition in which urine flows backwards towards the kidneys, increasing the risk of recurrent infections. With a liver transplant being considered and the risk of infection, needing to be minimized, the urinary abnormality had to be addressed before transplantation. The child therefore underwent a successful ureteric reimplantation surgery to reposition the ureter and correct the underlying abnormality. A temporary stent was subsequently placed to support the urinary system and reduce the risk of further infections during the transplant process.
Navigating this intricate medical puzzle required seamless collaboration across multiple specialties. A dedicated expert team at Rainbow ChildrenтАЩs Hospital, comprising Pediatric Nephrologists, Pediatric Surgeons, Hepatologists, Pediatric Transplant Surgeons, Pediatric Hemato-Oncologists, and Pediatric Intensivists came together to execute a carefully staged treatment plan to manage the complications, determine the appropriate sequence of interventions, stabilise the child and prepare him for liver transplantation. Once the urinary abnormality had been corrected and the child was medically stabilised, the liver transplant was successfully performed approximately three weeks later. The child underwent a living donor liver transplant, receiving a portion of his fatherтАЩs liver, who was found to be a suitable donor following detailed evaluation. The transplant was performed by Dr. Mettu Srinivas Reddy, Group Director тАУ Department of Liver Transplantation & HPB Surgery, Rainbow ChildrenтАЩs Hospital, Chennai along with Dr. Somashekara H R, Senior Consultant тАУ Pediatric Hepatology & Liver Transplantation, Rainbow ChildrenтАЩs Hospital, Guindy with the multidisciplinary team of doctors Dr. Prahlad N, Senior Consultant тАУ Pediatric Nephrology & Kidney Transplant, Dr. Prasanna Gopal, Pediatric Transplant Surgeon, Dr. Nandhini G, Senior Consultant – Pediatric surgeon and Urologist, Dr. Karthik Narayanan R & Dr. Nataraj P, Consultants – Pediatric Intensive Care, Dr. Meena Sivasankaran, Consultant Pediatric Hemato-oncologist, and Dr. Sathish Chander, who led the anesthesiology department. The living donor liver transplant involved transplantation of the left lateral segment of the donor liver, with the procedure lasting approximately 10 hours. Following the transplant, the child was closely monitored for 8 weeks and after which he continued to receive disease-directed chemotherapy for LCH. He subsequently completed four additional rounds of chemotherapy, with follow-up evaluations showing no evidence of LCH and resolution of the recurrent urine infections. Speaking on the occasion, Dr. Somashekara H R, Senior Consultant тАУ Pediatric Hepatology & Liver Transplantation, Rainbow ChildrenтАЩs Hospital, said, тАЬThis was an exceptionally complex case because we were not dealing with a single problem. We had to manage a rare systemic disease with severe liver involvement, while also dealing with the limitations that the liver dysfunction placed on chemotherapy. When recurrent infections emerged, we had to identify and correct the underlying urinary abnormality before the child could proceed to transplant. Each decision had to be carefully coordinated with the next. The involvement of our hemato-oncology, hepatology and liver transplant, nephrology and urology teams allowed us to address these challenges together and take the child through treatment in a planned and coordinated manner.тАЭ Adding on to this case, Dr. Mettu Srinivas Reddy, Group Director тАУ Department of Liver Transplantation & HPB Surgery, Rainbow ChildrenтАЩs Hospital, said, тАЬPerforming a liver transplant in a 3.5-year-old child with significant liver involvement and multiple associated medical complications requires meticulous planning at every stage. Before transplantation, the child had to be stabilised and the recurrent infections and congenital
urinary abnormality had to be appropriately addressed. From the surgical perspective, ensuring that the child was medically optimized and ready for transplantation was critical.
The successful transplant was made possible through close coordination between the transplant, pediatric, oncology, nephrology and urology teams, followed by careful post-transplant monitoring and continued treatment for the underlying condition.тАЭ Elaborating on the treatment journey, Dr. Prahlad N, Senior Consultant тАУ Pediatric Nephrology & Kidney Transplant, Rainbow ChildrenтАЩs Hospital, said, тАЬRecurrent urinary infections added another significant challenge to the childтАЩs treatment. Given the need for a liver transplant, it was important to identify the reason behind these repeated infections and address it beforehand. Our evaluation, along with the urology team, identified vesicoureteric reflux. Gross reflux in a immunocompromised child like him, negating reflux. This was done by continuous bladder drainage with a silicon folleys prior and after anti reflux surgery. Permanent Correction of this condition was important to reduce the risk of further infections and ensure that the child was medically optimized before transplantation. Managing these associated problems alongside the primary condition was an important part of preparing the child for the next stage of treatment.тАЭ Further to this, Dr. Nandhini G, Senior Consultant тАУ Pediatric Surgeon and Urologist, Rainbow ChildrenтАЩs Hospital, Guindy, said, тАЬRecurrent urinary infections became an important concern as the child was being prepared for liver transplantation. Further evaluation identified congenital vesicoureteric reflux, where urine flows backwards towards the kidneys, increasing the risk of repeated infections. We performed ureteric reimplantation surgery with stent placement to correct the abnormality and close monitoring. Addressing the urinary condition before transplantation was important to reduce the risk of further infections and ensure that the child was medically stable for the next stage of treatment. The child was subsequently able to proceed with the liver transplant after recovering from the procedure. About Rainbow ChildrenтАЩs Medicare Limited: Rainbow ChildrenтАЩs Medicare Limited has a network of 26 hospitals across 11 cities, supported by 6 outpatient clinics and 2 exclusive IVF centres, with a total capacity of 2,505 beds .Our Pediatric services operating under the brand тАЬRainbow ChildrenтАЩs HospitalтАЭ includes new-born and pediatric intensive care, pediatric multi-specialty services, pediatric quaternary care (including organ transplantation); whereas our women care services under тАЬBirthright by RainbowтАЭ offers perinatal care services which includes normal and complex obstetric care, multi-disciplinary foetal care, perinatal genetic and fertility care along with gynecology services. Rainbow ChildrenтАЩs Hospital built on strong fundamentals of a multidisciplinary approach with a full-time consultant-led clinical service along with 24/7 commitment in a child centric environment. The company follows a hub-and-spoke operating model where the hub hospital provides comprehensive outpatient, inpatient care, with a focus on tertiary and quaternary services, while the spokes provide 24/7 emergency care, large outpatient services and comprehensive obstetrics, pediatric inpatient and level 3 NICU services. This model is successfully operational at Hyderabad and is gaining traction in Bengaluru. The endeavor is to replicate this approach in Chennai and across the National Capital Region. Subsequently Rainbow intends to expand into tier-2 cities of Southern India.Rainbow ChildrenтАЩs Hospital embraces a unique doctor engagement model, where doctors work
exclusively on a full-time. The doctors work in teams and have 24/7 commitment, which is particularly important for childrenтАЩs emergency, neonatal, pediatric intensive care services and to support pediatric retrieval services. The Company also operates the countryтАЩs largest pediatric DNB training programme in private healthcare, offering post graduate residential DNB and fellowship programmes.
deccanwebtv 
